About Yun Li
Form D filings for Nob Hill Therapeutics from 2018 to 2021 list Yun Li as chief executive officer and director.
Yun Li first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Yun Li in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Yun Li works with at each company, as listed on that company's latest Form D.
Nob Hill Therapeutics, Inc. · Form D/A, Sep 20, 2021
PA
Paul Atkins
Director
RG
Robert Goforth
Director